Pharmacogenomics and genetics of primary hypertension Giuseppe Bianchi Invited Commentary Pages: 441 - 443
Hypertension and dementia Anne-Sophie RigaudOlivier HanonFrançoise Forette OriginalPaper Pages: 454 - 457
Quality-of-Life measures as predictors of mortality and morbidity Ruth Peters OriginalPaper Pages: 458 - 461
The relationship between quality of life and adherence to treatment Maria I. Nunes OriginalPaper Pages: 462 - 465
Quality of life with nonpharmacologic treatment of hypertension Joseph P. RoelCarrie L. HildebrantRichard H. Grimm Jr OriginalPaper Pages: 466 - 472
Actual practice in hypertension: Implications for persistence with and effectiveness of therapy Jeffrey D. SpenceThomas C. HurleyJ. David Spence OriginalPaper Pages: 481 - 487
Novel mechanisms contributing to cerebral vascular dysfunction during chronic hypertension Christopher G. SobeyFrank M. Faraci OriginalPaper Pages: 517 - 523
Long-term efficacy of a new, fixed, very-low-dose angiotension converting enzyme inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients George MansourJanette Mansour Clinical Trials Report Pages: 524 - 524